Clinical Trial Update: Clinical Study and Molecular Mechanism of Xuesaitong Soft Capsule in the Treatment of Acute Coronary Syndrome [Phase 1, Phase 2]

View source ↗

Summary

Clinical study evaluating Xuesaitong Soft Capsule for acute coronary syndrome has completed Phase 1 and Phase 2 trials.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• Xuesaitong Soft Capsule

Snippet

Sponsor: Xiyuan Hospital of China Academy of Chinese Medical Sciences | Conditions: Acute Coronary Syndrome | Phase 1, Phase 2 | Status: COMPLETED